Company: NCEL
Filing Date: 2025-06-09
Form Type: F-4/A
Source: 0001213900-25-052354
Chunk: 694

Company: NewcelX Ltd.
Filing Date: 2025-06-09
Form: F-4/A
Chunk 694
---
, kidneys and feet to facilitate early treatment. ____________ 1Worldometer — Countries in the world by population (2024) — https://www.worldometers.info/world-population/population-by-country/ 2CDC — National ALS registry dashboard — https://www.cdc.gov/als/dashboard/index.html 3Carolyn A. Brown, Cathy Lally, Varant Kupelian, W. Dana Flanders; Estimated Prevalence and Incidence of Amyotrophic Lateral Sclerosis and SOD1 and C9orf72 Genetic Variants. Neuroepidemiology 16 September 2021; 55 (5): 342–353. — https://doi.org/10.1159/000516752

| Moore Financial Consulting |

Annex E-16

Diabetes Prevalence According to the International Diabetes Federation (“IDF”) data, there were approx. 537 million people from the 20 – 79 age group worldwide living with diabetes (2021 data). This represents 10.5% of the world’s population in this age group. The total number is predicted to rise to 643 million (11.3%) by 2030 and to 783 million (12.2%) by 2045. In the following table are the IDF’s estimated global number of persons with Diabetes by territory:

| Region                       |     | -000’ |     |    2021 |     |     % |   |     |    2030 |     | Growth |   |
| Africa                       |     |       |     |  23,634 |     |   4.4 | % |     |  33,446 |     |   41.5 | % |
| Europe                       |     |       |     |  61,425 |     |  11.4 | % |     |  67,000 |     |    9.1 | % |
| Middle East and North Africa |     |       |     |  72,672 |     |  13.5 | % |     |  95,000 |     |   30.7 | % |
| North America and Caribbean  |     |       |     |  50,547 |     |   9.4 | % |     |  57,000 |     |   12.8 | % |
| South and Central America    |     |       |     |  32,497